Fig 1.
Flow chart showing the selection of the study population.
The PEX group comprised 35 patients with PXS and 13 patients with PXG. PEX: pseudoexfoliation; PXG: PEX glaucoma; PXS: PEX syndrome.
Table 1.
Visual rating scales of brain atrophy.
Table 2.
Clinical characteristics of participants included in the study.
Fig 2.
Brain atrophy in structural MRI using visual rating scales.
(A) Medial temporal atrophy according to Scheltens scale with oblique coronal T2-weighted images. (B) Global cortical atrophy graded on axial FLAIR images. (C) Parietal atrophy scored using the posterior cortical atrophy scale with axial FLAIR images. FLAIR: fluid-attenuated inversion recovery.
Table 3.
Brain atrophy in the PEX and control groups.
Fig 3.
MMSE score distribution in patients with AD.
(A) The PEX group had mainly mild MMSE scores in patients with AD. (B) The PXG group showed higher MMSE score severity than the PXS group. AD: Alzheimer’s disease; MMSE: Mini-Mental State Examination; PEX: pseudoexfoliation; PXG: PEX glaucoma; PXS: PEX syndrome.